Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced Gastropathy.
Phase of Trial: Phase IV
Latest Information Update: 23 Aug 2011
At a glance
- Drugs Esomeprazole; Rebamipide
- Indications NSAID-induced gastric damage
- Focus Pharmacodynamics
- Sponsors Otsuka Pharmaceutical
- 10 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2010 Actual end date (Mar 2010) added as reported by ClinicalTrials.gov.
- 30 Dec 2009 New trial record